Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorenzo Monserrat

Showing results (81-90 of 160) with videos related to

Pageof 16
Sort By:
Human Genetics|April 14, 2011
Novel human pathological mutations. Gene symbol: MYBPC3. Disease: cardiomyopathy, hypertrophicMaría Isabel Rodriguez-Garcia, Lorenzo Monserrat, Martín Ortiz, et al.
Human Genetics|April 14, 2011
Novel human pathological mutations. Gene symbol: MYBPC3. Disease: cardiomyopathy, hypertrophicMaría Isabel Rodriguez-Garcia, Lorenzo Monserrat, Martín Ortiz, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 3, 2023
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-makingNathan Green, Yang Chen, Constantinos O'Mahony, et al.
Circulation. Genomic and Precision Medicine|May 13, 2020
Cryptic Splice-Altering Variants in <i>MYBPC3</i> Are a Prevalent Cause of Hypertrophic CardiomyopathyLuis R Lopes, Pedro Barbosa, Mario Torrado, et al.
European Heart Journal|October 16, 2013
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)Constantinos O'Mahony, Fatima Jichi, Menelaos Pavlou, et al.
European Heart Journal|October 26, 2018
The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathyYishay Wasserstrum, Roberto Barriales-Villa, Xusto Fernández-Fernández, et al.
Heart (British Cardiac Society)|October 30, 2014
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathyLuis R Lopes, Petros Syrris, Oliver P Guttmann, et al.
Revista Espanola De Cardiologia|January 29, 2003
[Exercise echocardiography to differentiate dilated cardiomyopathy from ischemic left ventricular dysfunction]Jesús Peteiro Vázquez, Lorenzo Monserrat Iglesias, Eugenia Vázquez Rey, et al.
Circulation|December 21, 2018
Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of CardiomyocytesNili Naftali-Shani, Natali Molotski, Yael Nevo-Caspi, et al.
Heart (British Cardiac Society)|April 19, 2017
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathyMatteo Dal Ferro, Davide Stolfo, Alessandro Altinier, et al.
Pageof 16

Showing results (81-90 of 160) with videos related to

Sort By:
Pageof 16
Human Genetics|April 14, 2011
Novel human pathological mutations. Gene symbol: MYBPC3. Disease: cardiomyopathy, hypertrophicMaría Isabel Rodriguez-Garcia, Lorenzo Monserrat, Martín Ortiz, et al.
Human Genetics|April 14, 2011
Novel human pathological mutations. Gene symbol: MYBPC3. Disease: cardiomyopathy, hypertrophicMaría Isabel Rodriguez-Garcia, Lorenzo Monserrat, Martín Ortiz, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 3, 2023
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-makingNathan Green, Yang Chen, Constantinos O'Mahony, et al.
Circulation. Genomic and Precision Medicine|May 13, 2020
Cryptic Splice-Altering Variants in <i>MYBPC3</i> Are a Prevalent Cause of Hypertrophic CardiomyopathyLuis R Lopes, Pedro Barbosa, Mario Torrado, et al.
European Heart Journal|October 16, 2013
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)Constantinos O'Mahony, Fatima Jichi, Menelaos Pavlou, et al.
European Heart Journal|October 26, 2018
The impact of diabetes mellitus on the clinical phenotype of hypertrophic cardiomyopathyYishay Wasserstrum, Roberto Barriales-Villa, Xusto Fernández-Fernández, et al.
Heart (British Cardiac Society)|October 30, 2014
Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathyLuis R Lopes, Petros Syrris, Oliver P Guttmann, et al.
Revista Espanola De Cardiologia|January 29, 2003
[Exercise echocardiography to differentiate dilated cardiomyopathy from ischemic left ventricular dysfunction]Jesús Peteiro Vázquez, Lorenzo Monserrat Iglesias, Eugenia Vázquez Rey, et al.
Circulation|December 21, 2018
Modeling Peripartum Cardiomyopathy With Human Induced Pluripotent Stem Cells Reveals Distinctive Abnormal Function of CardiomyocytesNili Naftali-Shani, Natali Molotski, Yael Nevo-Caspi, et al.
Heart (British Cardiac Society)|April 19, 2017
Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathyMatteo Dal Ferro, Davide Stolfo, Alessandro Altinier, et al.
Pageof 16